Studies in animal models have further supported these findings, showing that resveratrol alleviates choroidal neovascularization (CNV) by modulating the hypoxia-inducible factor 1-alpha (HIF-1α)/VEGF/VEGFR2 pathway [28]. This evidence concerns the gene VEGFA and choroidal neovascularization.